Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Yin

Showing results (431-440 of 470) with videos related to

Pageof 47
Sort By:
Cancer Immunity|January 13, 2006
Glycoprotein A34, a novel target for antibody-based cancer immunotherapyMatthew J Scanlan, Gerd Ritter, Beatrice W T Yin, et al.
The Lancet. Infectious Diseases|November 3, 2022
Resistance of SARS-CoV-2 omicron subvariant BA.4.6 to antibody neutralisationQian Wang, Zhiteng Li, Jerren Ho, et al.
Emerging Microbes & Infections|September 15, 2020
SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe diseasePengfei Wang, Lihong Liu, Manoj S Nair, et al.
Scientific Reports|July 14, 2021
Placental response to maternal SARS-CoV-2 infectionMirella Mourad, Taylor Jacob, Elena Sadovsky, et al.
Msphere|February 7, 2020
Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral TherapyMedini K Annavajhala, Sabrina D Khan, Sean B Sullivan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 25, 2019
Polypharmacy, Hazardous Alcohol and Illicit Substance Use, and Serious Falls Among PLWH and Uninfected ComparatorsJulie A Womack, Terrence E Murphy, Christopher T Rentsch, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 18, 2020
Application of Selected Muscle Strength and Body Mass Cut Points for the Diagnosis of Sarcopenia in Men and Women With or at Risk for HIV InfectionKristine M Erlandson, Thomas G Travison, Hao Zhu, et al.
Nature|July 5, 2022
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5Qian Wang, Yicheng Guo, Sho Iketani, et al.
Nature|March 8, 2021
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7Pengfei Wang, Manoj S Nair, Lihong Liu, et al.
Nature|March 3, 2022
Antibody evasion properties of SARS-CoV-2 Omicron sublineagesSho Iketani, Lihong Liu, Yicheng Guo, et al.
Pageof 47

Showing results (431-440 of 470) with videos related to

Sort By:
Pageof 47
Cancer Immunity|January 13, 2006
Glycoprotein A34, a novel target for antibody-based cancer immunotherapyMatthew J Scanlan, Gerd Ritter, Beatrice W T Yin, et al.
The Lancet. Infectious Diseases|November 3, 2022
Resistance of SARS-CoV-2 omicron subvariant BA.4.6 to antibody neutralisationQian Wang, Zhiteng Li, Jerren Ho, et al.
Emerging Microbes & Infections|September 15, 2020
SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe diseasePengfei Wang, Lihong Liu, Manoj S Nair, et al.
Scientific Reports|July 14, 2021
Placental response to maternal SARS-CoV-2 infectionMirella Mourad, Taylor Jacob, Elena Sadovsky, et al.
Msphere|February 7, 2020
Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral TherapyMedini K Annavajhala, Sabrina D Khan, Sean B Sullivan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 25, 2019
Polypharmacy, Hazardous Alcohol and Illicit Substance Use, and Serious Falls Among PLWH and Uninfected ComparatorsJulie A Womack, Terrence E Murphy, Christopher T Rentsch, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 18, 2020
Application of Selected Muscle Strength and Body Mass Cut Points for the Diagnosis of Sarcopenia in Men and Women With or at Risk for HIV InfectionKristine M Erlandson, Thomas G Travison, Hao Zhu, et al.
Nature|July 5, 2022
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5Qian Wang, Yicheng Guo, Sho Iketani, et al.
Nature|March 8, 2021
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7Pengfei Wang, Manoj S Nair, Lihong Liu, et al.
Nature|March 3, 2022
Antibody evasion properties of SARS-CoV-2 Omicron sublineagesSho Iketani, Lihong Liu, Yicheng Guo, et al.
Pageof 47